JOSHUA VANDERBUR: Open Payments
NPI 1417424144 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$774 in 33 payments from 9 companies in 2025. Trend: 2023 $13 · 2024 $309 · 2025 $774
Food & beverage: $774
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 11 | $291 |
| Gilead Sciences, Inc. | 12 | $261 |
| Theratechnologies Inc. | 3 | $74 |
| Exact Sciences Corporation | 2 | $41 |
| Alkermes, Inc. | 1 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| ABBVIE INC. | 1 | $14 |
| Napo Pharmaceuticals Inc | 1 | $14 |
Products named: APRETUDE, EGRIFTA, DOVATO, The Cologuard Plus Collection Kit, CABENUVA, VIVITROL, Epclusa, CAPLYTA.
Industry payments across IN — which companies pay providers there.
